BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Wernicke Encephalopathy

Below is an extended Wernicke Encephalopathy patents listing. Click here to return to the Wernicke Encephalopathy main in depth entry.

Patents :

US Patent No.Title
6433145 Keratinocyte derived interferon
6770466 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
6824993 Antibodies that bind human prostate specific G-protein receptor HPRAJ70
6878806 Human secreted protein HTEEB42
6905688 Albumin fusion proteins
6919433 Antibodies to protein HPMBQ91
6926898 Albumin fusion proteins
6936688 Human chemokine beta-10 mutant polypeptides
6936691 Secreted protein HCE3C63
6946134 Albumin fusion proteins
6951924 Antibodies against secreted protein HTEBYII
6761904 Pharmaceutical kit comprising midodrine as active drug substance
6753164 Nucleic acids encoding human serpin polypeptide HMCIS41
6743613 Lysyl-oxidase HOHEC84 polynucleotides
6448241 Thiazolobenzoheterocycles, their preparation and medicaments containing them
6472512 Keratinocyte derived interferon
6503947 Method of treating cytotoxic damage
6506550 Method of including apoptosis by reducing the level of thiamin
6593112 Polynucleotides encoding fibroblast growth factor 15
6605441 Antibodies against fibroblast growth factor 11
6605592 Protein HOFNF53
6613740 Activity dependent neurotrophic factor III (ADNF III)
6693077 Keratinocyte growth factor-2
6713468 Methods of using thiazolobenzoheterocycles
6994857 Albumin fusion proteins
7026447 53 human secreted proteins
7235529 Brain-associated inhibitor of tissue-type plasminogen activator
7238660 Albumin fusion proteins
7238667 Albumin fusion proteins
7264947 Activity dependent neurotrophic factor III (ADNF III)
7304029 Neuroprotective effect of growth hormone
7312238 Nonsedating .alpha.-2 agonists
7368531 Human secreted proteins
7381800 Antibodies to HBIMF63 polypeptide
7390637 Keratinocyte derived interferon
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7232667 Keratinocyte growth factor-2 polynucleotides
7205139 Tissue plasminogen activator-like protease
7189690 Albumin fusion proteins
7041661 Use of thiazolobenzoheterocycles for treating multiple sclerosis
7041803 Galectin 11
7070803 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
7078186 Apoptosis related polynucleotides, polypeptides, and antibodies
7091315 Protein HDPBQ71
7141547 Albumin fusion proteins comprising GLP-1 polypeptides
7141597 Nonsedating .alpha.-2 agonists
7163797 50 human secreted proteins
7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10
7179909 Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type
7411051 Antibodies to HDPPA04 polypeptide
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional